Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
52.76B | 48.37B | 44.45B | 39.71B | 39.34B | Gross Profit |
10.34B | 9.64B | 8.70B | 7.20B | 7.25B | EBIT |
5.12B | 5.00B | 4.46B | 3.48B | 3.56B | EBITDA |
6.22B | 5.44B | 5.33B | 4.42B | 3.79B | Net Income Common Stockholders |
3.73B | 3.33B | 3.24B | 2.63B | 2.42B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
15.79B | 11.79B | 12.80B | 11.50B | 9.97B | Total Assets |
39.71B | 33.64B | 33.14B | 30.34B | 26.77B | Total Debt |
2.39B | 1.03B | 1.57B | 1.92B | 2.56B | Net Debt |
-12.59B | -10.00B | -10.28B | -9.12B | -6.85B | Total Liabilities |
12.03B | 9.19B | 11.00B | 10.86B | 10.58B | Stockholders Equity |
27.68B | 24.45B | 22.13B | 19.49B | 16.19B |
Cash Flow | Free Cash Flow | |||
2.95B | 1.28B | 3.01B | 2.97B | 3.29B | Operating Cash Flow |
3.21B | 1.68B | 3.22B | 3.16B | 3.69B | Investing Cash Flow |
1.45B | -874.88M | -1.16B | -47.41M | 2.41M | Financing Cash Flow |
-723.69M | -1.63B | -1.35B | -1.48B | -511.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
$456.47M | 13.42 | 14.89% | 2.96% | ― | ― | ||
62 Neutral | $11.81B | 10.34 | -7.44% | 2.91% | 7.41% | -7.93% | |
$393.09M | 18.89 | 17.71% | 2.56% | ― | ― | ||
77 Outperform | ¥58.80B | 15.51 | 2.50% | 9.68% | -2.04% | ||
68 Neutral | ¥40.41B | 11.03 | 3.13% | 4.53% | -6.57% | ||
67 Neutral | ¥37.66B | 17.30 | 2.15% | 18.56% | 43.88% | ||
66 Neutral | ¥72.35B | 19.60 | 3.50% | -0.93% | -37.97% |